BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
See today's BioWorld Asia
Home
» In the clinic for Aug. 31-Sept. 3, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
In the clinic for Aug. 31-Sept. 3, 2021
Sep. 7, 2021
No Comments
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Adamis, Amarin, Code, Connect, Curevac, Daiichi-Sankyo, Exevir, Gennova, Glaxosmithkline, HDT, Immutep, Merck, Nrx, Pfizer, Pharmaxis, Quantum Leap Healthcare Collaborative, Ridgeback, Rigel, Senhwa, SK Bioscience, Takeda, Tevogen.
BioWorld Asia
Briefs
In the clinic